跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PERINDOPRIL/INDAPAMIDE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PERINDOPRIL/INDAPAMIDE
Authorized
STANDARD
PERINDOPRIL/INDAPAMIDE
sanis health inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
0d158653ee0af49a
Company
sanis health inc
Type
Standard
Approval Details
Approval Id
0d158653ee0af49a
Drug Approval Canada Name
PERINDOPRIL/INDAPAMIDE
Product Name
PERINDOPRIL/INDAPAMIDE
Status
Marketed
Status Date
2021-12-15
Original Market Date
2021-12-15
Din
02519739
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:32.04
Atc Original
C09BA04 PERINDOPRIL AND DIURETICS
Atc Name
c 09 ba 04
Aig Number
0248401003
Company Name
sanis health inc
Company Address
1 Presidents Choice Circle, Brampton, Ontario, Canada, L6Y 5S5
Active Ingredients
PERINDOPRIL ERBUMINE
8 MG
INDAPAMIDE
2.5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
0d158653ee0af49a
Type
Standard
Back to Health Canada Approvals